Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1978 Mar;41(3):272–277. doi: 10.1136/jnnp.41.3.272

Electroencephalography and phenytoin toxicity in mentally retarded epileptic patients.

M Iivanainen, M Viukari, A M Seppäläinen, E P Helle
PMCID: PMC493006  PMID: 632825

Abstract

There were significantly more diffuse and focal electroencephalographic abnormalities in 127 mentally retarded epileptic patients treated with phenytoin than in 68 epileptics without phenytoin. Phenytoin intoxication made the difference still more pronounced. Monitoring drug levels and electroencephalograms appears to be the method of choice for ensuring safe and effective medication in intractable epilepsy.

Full text

PDF
272

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahmad S., Laidlaw J., Houghton G. W., Richens A. Involuntary movements caused by phenytoin intoxication in epileptic patients. J Neurol Neurosurg Psychiatry. 1975 Mar;38(3):225–231. doi: 10.1136/jnnp.38.3.225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BUCHTHAL F., SVENSMARK O., SCHILLER P. J. Clinical and electroencephalographic correlations with serum levels of diphenylhydanotin. Arch Neurol. 1960 Jun;2:624–630. doi: 10.1001/archneur.1960.03840120030004. [DOI] [PubMed] [Google Scholar]
  3. Bente D. Antikonvulsiva und Elektroenzephalogramm. Bibl Psychiatr. 1975;(151):182–189. [PubMed] [Google Scholar]
  4. Dow W. I. Electroencephalogram in anticonvulsant-induced folate deficiency. Br Med J. 1971 Apr 24;2(5755):207–207. doi: 10.1136/bmj.2.5755.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fink M. EEG and human psychopharmacology. Annu Rev Pharmacol. 1969;9:241–258. doi: 10.1146/annurev.pa.09.040169.001325. [DOI] [PubMed] [Google Scholar]
  6. Ghatak N. R., Santoso R. A., McKinney W. M. Cerebellar degeneration following long-term phenytoin therapy. Neurology. 1976 Sep;26(9):818–820. doi: 10.1212/wnl.26.9.818. [DOI] [PubMed] [Google Scholar]
  7. Iivanainen M., Viukari M., Helle E. P. Cerebellar atrophy in phenytoin-treated mentally retarded epileptics. Epilepsia. 1977 Sep;18(3):375–386. doi: 10.1111/j.1528-1157.1977.tb04980.x. [DOI] [PubMed] [Google Scholar]
  8. Iivanainen M., Viukari M. Serum-phenytoin, seizures, and electroencephalography. Lancet. 1977 Apr 16;1(8016):860–861. doi: 10.1016/s0140-6736(77)92815-x. [DOI] [PubMed] [Google Scholar]
  9. Jensen B. N., Grynderup V. Studies on the metabolism of phenytoin. Epilepsia. 1966 Sep;7(3):238–245. doi: 10.1111/j.1528-1157.1966.tb03802.x. [DOI] [PubMed] [Google Scholar]
  10. LEVY L. L., FENICHEL G. M. DIPHENYLHYDANTOIN ACTIVATED SEIZURES. Neurology. 1965 Aug;15:716–722. doi: 10.1212/wnl.15.8.719. [DOI] [PubMed] [Google Scholar]
  11. Lambie D. G., Johnson R. H., Nanda R. N., Shakir R. A. Therapeutic and pharmacokinetic effects of increasing phenytoin in chronic epileptics on multiple drug therapy. Lancet. 1976 Aug 21;2(7982):386–389. doi: 10.1016/s0140-6736(76)92405-3. [DOI] [PubMed] [Google Scholar]
  12. Le Quesne P. M., Goldberg V., Vajda F. Acute conduction velocity changes in guinea-pigs after administration of diphenylhydantoin. J Neurol Neurosurg Psychiatry. 1976 Oct;39(10):995–1000. doi: 10.1136/jnnp.39.10.995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Logan W. J., Freeman J. M. Pseudodegenerative disease due to diphenylhydantoin intoxication. Arch Neurol. 1969 Dec;21(6):631–637. doi: 10.1001/archneur.1969.00480180087008. [DOI] [PubMed] [Google Scholar]
  14. MORRELL F., BRADLEY W., PTASHNE M. Effect of drugs on discharge characteristics of chronic epileptogenic lesions. Neurology. 1959 Jul;9(7):492–498. doi: 10.1212/wnl.9.7.492. [DOI] [PubMed] [Google Scholar]
  15. McLellan D. L., Swash M. Choreo-athetosis and encephalopathy induced by phenytoin. Br Med J. 1974 Apr 27;2(5912):204–205. doi: 10.1136/bmj.2.5912.204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Müller J., Müller D. Hirnelektrische Korrelate bei Uberdosierung von antikonvulsiven Medikamenten. Nervenarzt. 1972 May;43(5):270–272. [PubMed] [Google Scholar]
  17. Porter R. J., Penry J. K., Lacy J. R. Diagnostic and therapeutic reevaluation of patients with intractable epilepsy. Neurology. 1977 Nov;27(11):1006–1011. doi: 10.1212/wnl.27.11.1006. [DOI] [PubMed] [Google Scholar]
  18. ROSEMAN E. Dilantin toxicity. A clinical and electroence-phalographic study. Neurology. 1961 Oct;11:912–921. doi: 10.1212/wnl.11.10.912. [DOI] [PubMed] [Google Scholar]
  19. STENSRUD P. A., PALMER H. SERUM PHENYTOIN DETERMINATIONS IN EPILEPTICS. Epilepsia. 1964 Dec;5:364–370. doi: 10.1111/j.1528-1157.1964.tb03342.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES